Gkv Capital Management Co., Inc. Vertex Pharmaceuticals Inc Transaction History
Gkv Capital Management Co., Inc.
- $120 Billion
- Q1 2025
A detailed history of Gkv Capital Management Co., Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Gkv Capital Management Co., Inc. holds 22 shares of VRTX stock, worth $9,757. This represents 0.01% of its overall portfolio holdings.
Number of Shares
22
Previous 3,738
99.41%
Holding current value
$9,757
Previous $1.51 Billion
99.29%
% of portfolio
0.01%
Previous 0.61%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,833Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.7 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.45 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.45 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.23 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $114B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...